Cargando…
JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
Autores principales: | Shahriari, Neda, Strober, Bruce, Shahriari, Mona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982443/ https://www.ncbi.nlm.nih.gov/pubmed/36873051 http://dx.doi.org/10.1016/j.jdcr.2023.01.020 |
Ejemplares similares
-
Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
por: Maudinet, Adrien, et al.
Publicado: (2019) -
Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
por: Esposito, Maria, et al.
Publicado: (2022) -
Dupilumab therapy following JAK inhibitor withdrawal in moderate–severe atopic dermatitis
por: Kiely, Lisa, et al.
Publicado: (2022) -
Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: A retrospective case series
por: Arnold, Kathryn A., et al.
Publicado: (2018) -
Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
por: Deng, Lin, et al.
Publicado: (2022)